Add Yahoo as a preferred source to see more of our stories on Google. Scientists at Northwestern University have discovered a highly toxic form of amyloid beta that appears early in Alzheimer’s ...

Move over, amyloid, reactive astrocytes and activated microglia may be the main drivers of the Alzheimer’s disease pathological cascade. In the November 6 Nature Neuroscience, scientists led by Pedro ...

Growing evidence suggests that the key to treating Alzheimer's is catching it in its earliest stages. Now scientists have developed a promising new drug that seems to be effective at stalling the ...

More than a century ago, Alois Alzheimer noted unusual changes in brain fats, which he described as "lipoid granules," along with the buildup of amyloid‐beta (amyloid) plaques and tau protein tangles.

Alzheimer's disease (AD) is a highly debilitating neurodegenerative disease characterized by the progressive loss of memory and decline of mental functions. Earlier research has uncovered some of the ...

Astrocytes, the predominant glial population in the human central nervous system, play crucial roles in neuroprotection, immunity, and homeostasis. However, when exposed to certain neuroinflammatory ...

How do astrocytes react to Alzheimer’s disease pathology? It’s complicated, according to the largest single-nuclei RNA-Seq study of these cells published thus far. Scientists led by Sudeshna Das at ...

When the brain is injured in some way, a wide range of biochemical changes are triggered that can affect crucial brain cells known as astrocytes. They are a type of glial cell, and brain injuries ...

Early in Alzheimer’s disease, your brain can begin to change long before anyone notices a lost name or missed appointment. Toxic proteins quietly collect inside cells, support cells turn restless, and ...